We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

SCIENION and Axxin Jointly Collaborate

SCIENION and Axxin Jointly Collaborate

SCIENION and Axxin Jointly Collaborate

SCIENION and Axxin Jointly Collaborate

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "SCIENION and Axxin Jointly Collaborate"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

SCIENION AG and Axxin Pty Ltd. have announced that they have partnered to collaborate on an instrument reader system for the analysis of multiplexed microarrays on lateral flow immunoassay strips.

Lateral flow immunoassays represent popular point of care diagnostics, as they are easy to use, cost-effective and produce rapid results. Both companies, SCIENION and Axxin, take an active part in this market segment and contribute with its technologies towards products and services for its customers.

Joining forces in this field brings together SCIENION’s picoliter dispensing technology and Axxin’s proven track record in commercializing diagnostic instrument systems for point of care diagnostics. The first joint project will be the development of a colorimetric reader system for multiplexed lateral flow microarrays for point of care and R&D applications. Multiplexed lateral flow assays can benefit from a dedicated detection device that provides optimal and quantitative analysis of results that eye-only interpretation could not match.

A series of early field tests with selected beta customers has already been initiated and shows very promising results. Initial applications focus on lateral flow microarrays with the capability of analyzing up to 20 parameters for infectious diseases, drugs of abuse, and allergies.

Holger Eickhoff, CEO of SCIENION, says: “Axxin is a well-known provider of reader platforms and diagnostic products for lateral flow applications. When we met first earlier this year, we immediately anticipated the benefits of a collaboration to generate added value for our customers. Combining our expertise and technologies means leveraging integrated solutions from two ends. Multiplexing is a vital topic in lateral flow point of care diagnostics and I am convinced that our collaboration will result in breakthrough products in an otherwise mature market.”

Axxin CEO Andrew Lysikatos says: “Strategic alliances and collaborations are an important part of Axxin's overall strategy. Axxin is seeking commercial partnerships with leading companies to develop and provide world class low cost point of care platforms to address unmet needs. With SCIENION we found a perfect partner for the production of multiplexed lateral flow assays, as the capabilities of the sciFLEXARRAYER dispensing technology allow for miniaturization, multiplexing and precise spotting of dots and lines in any patterns favored.”